Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype. [electronic resource]
Producer: 20140811Description: 48-56 p. digitalISSN:- 1538-3598
- Adolescent
- Adult
- Aged
- Alemtuzumab
- Anemia, Sickle Cell -- complications
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Chimerism
- Erythrocytes
- Female
- Filgrastim
- Graft vs Host Disease
- Granulocyte Colony-Stimulating Factor
- HLA Antigens
- Hematopoietic Stem Cell Mobilization
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Humans
- Immunosuppressive Agents -- administration & dosage
- Infections -- etiology
- Male
- Middle Aged
- Pain -- etiology
- Prospective Studies
- Recombinant Proteins
- Sirolimus -- administration & dosage
- Transplantation Conditioning
- Transplantation, Homologous
- Treatment Outcome
- Whole-Body Irradiation
- Young Adult
- beta-Thalassemia -- complications
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Intramural
There are no comments on this title.
Log in to your account to post a comment.